Yves J. L. Bodar - Concepedia

Author

Yves J. L. Bodar

Amsterdam University Medical Centers ORCID

Also Known As

Y. Bodar, Y. J. L. Bodar, Y.J.L Bodar, Y.J.L. Bodar, Yashvant Pravinbhai Bodar, Yves Bodar, Yves J. L. Bodar, Yves J.L. Bodar, Yves Jan Lambert Bodar

Publications

406

Citations

H-Index

Concepts

All Affiliations

Amsterdam University Medical Centers The Netherlands Cancer Institute Ziekenhuis Amstelland Amsterdam UMC Location Vrije Universiteit Amsterdam Noordwest Ziekenhuisgroep

About

Yves J. L. Bodar is an author at Amsterdam University Medical Centers specializing in oncology, urology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	1	1	20
2	Medicine	1	1	20
3	Medical Imaging	1	1	20
4	Cancer Research	1	1	20
5	Nuclear Medicine	1	1	20

Yves J. L. Bodar

Publications

374

Citations

H-Index

Page 1

	Year	Citations
Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial - B.H.E. Jansen, Yves J. L. Bodar, Gerben J.C. Zwezerijnen, European Journal of Nuclear Medicine and Molecular Imaging	2020	104
Detection of prostate cancer with 18F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trial Yves J. L. Bodar, B.H.E. Jansen, J. Patrick van der Voorn, World Journal of Urology	2020	45
Repeatability of Quantitative <sup>18</sup>F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer B.H.E. Jansen, Matthijs C. F. Cysouw, André N. Vis, Journal of Nuclear Medicine	2020	28
Prospective analysis of clinically significant prostate cancer detection with [18F]DCFPyL PET/MRI compared to multiparametric MRI: a comparison with the histopathology in the radical prostatectomy specimen, the ProStaPET study Yves J. L. Bodar, Gerben J.C. Zwezerijnen, Patrick J. van der Voorn, European Journal of Nuclear Medicine and Molecular Imaging	2021	27
Standardised uptake values as determined on prostate‐specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients with prostate cancer Yves J. L. Bodar, Hans Veerman, Dennie Meijer, British Journal of Urology	2022	26
Slow induction of brain death leads to decreased renal function and increased hepatic apoptosis in rats Rolando Rebolledo, Dane Hoeksma, C. Hottenrott, Journal of Translational Medicine	2016	24
Biochemical Persistence of Prostate-specific Antigen after Robot-assisted Laparoscopic Radical Prostatectomy: Tumor localizations using PSMA PET/CT imaging Dennie Meijer, Maarten L. Donswijk, Yves J. L. Bodar, Journal of Nuclear Medicine	2020	20
The clinical characteristics of patients with primary non‐prostate‐specific membrane antigen‐expressing prostate cancer on preoperative positron emission tomography/computed tomography Hans Veerman, Maarten L. Donswijk, Elise M. Bekers, British Journal of Urology Positron Emission TomographyUrologyMedical ImagingGenitourinary CancerMedicine	2021	20
The Predictive Value of Preoperative Negative Prostate Specific Membrane Antigen Positron Emission Tomography Imaging for Lymph Node Metastatic Prostate Cancer Dennie Meijer, Hilda A. de Barros, Pim J. van Leeuwen, The Journal of Urology	2021	18
Management impact of 18F-DCFPyL PET/CT in hormone-sensitive prostate cancer patients with biochemical recurrence after definitive treatment: a multicenter retrospective study Dennie Meijer, Pim J. van Leeuwen, Pepijn M. J. Oosterholt, European Journal of Nuclear Medicine and Molecular Imaging	2021	14

Page 1